Axsome Therapeutics
As of the edition of 20 October 2026, Axsome Therapeutics runs 5 drugs, 1 of them marketed.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Family history
The records place 2 company names in this family.
Drugs by status
| Status | Count |
|---|---|
| Marketed | 1 |
| Active | 2 |
| Went quiet | 1 |
| Status not established | 1 |
| Total | 5 |
Marketed drugs and when their US protection ends
| Drug | US protection | Route B rows |
|---|---|---|
| Solriamfetol | Ends 2038 (patent) | 0 |
A route B row is one company at one target.
Where its trials are
- Mental health: 15 trials led
- Nervous system: 14 trials led
- Bones, joints and muscles: 3 trials led